Researchers at Rockefeller University build the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis, the bacterium that causes tuberculosis. The work identifies thousands of previously unknown genetic relationships, offering insight into how the pathogen’s biology is organized at the gene level.

Both reports describe the approach as using high-throughput CRISPR-interference to systematically probe gene function by measuring which essential genes affect one another. They also link the resulting interaction data to drug development aims, including understanding drug–target relationships and identifying opportunities for improved tuberculosis therapies. Phys.org frames the findings around how the map could help pair antibiotics, while Nature emphasizes the comprehensive mapping capability and the platform’s ability to reveal gene interactions and support new therapeutic directions.